Surgical Advances in Hepatocellular Carcinoma: Optimizing Patients for Resection and Transplant

Nov 16 2024
Convention Center: Ballroom 6D
8:00 AM - 9:30 AM
Captured

World Class Speakers

LK
Presenter

Laura Kulik

Northwestern Medical Faculty Foundation
CS
Presenter

Christopher Sonnenday, MD, MHS

University of Michigan Medical Center
Parissa Tabrizian, MD, FACS
Presenter

Parissa Tabrizian, MD, FACS

Icahn School of Medicine at Mount Sinai (ISMMS)
Neil Mehta, MD
Presenter

Neil Mehta, MD

University of California, San Francisco
Julie Heimbach, MD, FAASLD
Presenter

Julie Heimbach, MD, FAASLD

Mayo Clinic Rochester
Allison Kwong, MD
Moderator

Allison Kwong, MD

Stanford University Medical Center

Description

This liver cancer SIG program addresses the rapidly evolving surgical treatment options for HCC including resection and liver transplantation, which are making more patients with intermediate or even advanced stage disease potentially eligible for curative therapy. This session highlights the changing landscape of surgical options for HCC including identification and optimization of potential candidates for resection or transplant; advances in surgical techniques;  the risk-benefit ratio of liver transplantation; and access to liver transplantation.

Journey Maps

Objectives

  • Identify evolving approaches to patient selection and new surgical techniques for resection of HCC.
  • Recognize the risks and benefits of resection versus transplant for HCC.
  • Identify opportunities to improve the liver allocation system and access to liver transplantation for patients with HCC.
Chair

Andrew M Moon, MD, MPH

University of North Carolina